Kathryn E Wengel sold $2.4M of Johnson & Johnson (JNJ)

Executed Jun 11, disclosed Jun 12, 1 day later.

Value, as filed

$2.4M

10,000 sh × $241.15

Executed

Jun 11

the trade date, as filed

Disclosed

Jun 12

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KW Kathryn E Wengel EVP, Chief TO and Risk Officer profile →

Kathryn E Wengel (EVP, Chief TO and Risk Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Johnson & Johnson (JNJ). The largest single filing was $2.4M of JNJ (10,000 sh × $241.15, as filed), executed Jun 11.

The name

JNJ Johnson & Johnson JNJ · Healthcare · 86 filings in 24 months ticker →

Healthcare · Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→